GlaxoSmithKline's COPD drug Anoro receives European green light
LONDON (Reuters) - Anoro, a combination drug for chronic obstructive pulmonary disease (COPD) developed by GlaxoSmithKline and Theravance, has receive...
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/IsGF2I9iE6E/story01.htm
No comments:
Post a Comment